Publications with MCTN Affiliation 2025

1. Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis.
   Abu-Rumeileh S, Scholle L, Mensch A, Grosskopf H, Ratti A, Kolsch A, Stoltenburg-Didinger G, Conrad J, De Gobbi A, Barba L, Steinacker P, Klafki HW, Oeckl P, Halbgebauer S, Stapf C, Posa A, Kendzierski T, Silani V, Hausner L, Ticozzi N, Froelich L, Weishaupt JH, Verde F, and Otto M. Nat Commun. 2025. 16(1):2019.
   DOI: 10.1038/s41467-025-57144-7.
2. LSD: Mechanisms and relevance to the treatment of depression.
   Bouloufa A, Delcourte S, Delannay T, Rovera R, Lau T, Mouledous L, Dkhissi-Benyahya O, Guiard BP, and Haddjeri N. Neurosci Biobehav Rev. 2025. 179:106407.
   DOI: 10.1016/j.neubiorev.2025.106407.
3. The immunology of brain tumors.
   Bunse L, Bunse T, Kilian M, Quintana FJ, and Platten M. Sci Immunol. 2025. 10(112):eads0449.
   DOI: 10.1126/sciimmunol.ads0449.
4. Mass-Guided Single-Cell MALDI Imaging of Low-Mass Metabolites Reveals Cellular Activation Markers.
   Cairns JL, Huber J, Lewen A, Jung J, Maurer SJ, Bausbacher T, Schmidt S, Levkin PA, Sevin D, Gopfrich K, Koch P, Kann O, and Hopf C. Adv Sci (Weinh). 2025. 12(5):e2410506.
   DOI: 10.1002/advs.202410506.
5. Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen.
   Chih YC, Dietsch AC, Koopmann P, Ma X, Agardy DA, Zhao B, De Roia A, Kourtesakis A, Kilian M, Kramer C, Suwala AK, Stenzinger M, Boenig H, Blum A, Pienkowski VM, Aman K, Becker JP, Feldmann H, Bunse T, Harbottle R, Riemer AB, Liu HK, Etminan N, Sahm F, Ratliff M, Wick W, Platten M, Green EW, and Bunse L. Nat Commun. 2025. 16(1):1262.
   DOI: 10.1038/s41467-025-56547-w.
6. Neural correlates underlying high-frequency stimulation-induced secondary hyperalgesia in humans.
   Clarke S, Wanigasekera V, Rogers R, Caspani O, Mouraux A, Fardo F, Finnerup NB, Treede RD, and Tracey I. Pain Rep. 2025. 10(6):e1342.
   DOI: 10.1097/PR9.0000000000001342.
7. Preferential C-nociceptor stimulation facilitates peripheral axon reflex flare, but not secondary mechanical hyperalgesia.
   Daneffel L, Rukwied R, Schmelz M, Ruppen W, and Schneider T. Front Pain Res (Lausanne). 2025. 6:1556429.
   DOI: 10.3389/fpain.2025.1556429.
8. Exploring the value of a well-established conditioned pain modulation paradigm in women: a Translational Research in Pelvic Pain (TRiPP) study.
   Demetriou L, Perro D, Coxon L, Krassowski M, Lunde CE, Ferreira-Gomes J, Charrua A, Abreu-Mendes P, Arendt-Nielsen L, Aziz Q, Birch J, Garbutt K, Horne A, Hoffman A, Hummelshoj L, Meijlink J, Obendorf M, Pogatzki-Zahn E, Sasamoto N, Terry K, Treede RD, Vitonis A, Vollert J, Rahmioglu N, Becker CM, Cruz F, Missmer SA, Zondervan K, Sieberg CB, Nagel J, and Vincent K. Front Pain Res (Lausanne). 2025. 6:1439563.
   DOI: 10.3389/fpain.2025.1439563.
9. A systematic review and meta-analysis to identify vertical limits for a high-dose opioid therapy.
   Dickmann F, Stingl J, Lampert A, Mucke M, Peuckmann-Post V, Magerl W, Rolke R, and Weber S. Neurol Res Pract. 2025. 7(1):77.
   DOI: 10.1186/s42466-025-00437-5.
10. Andexanet alfa in patients with factor Xa inhibitor-associated intracranial hemorrhage: The prospective observational multicenter ASTRO-DE study.
    Diener HC, Kuklik N, Husing A, Alonso A, Nabavi DG, Poli S, Gabriel MM, Maier IL, and Grans J. Int J Stroke. 2025.
    DOI: 10.1177/17474930251317385.
11. Spatially Resolved Profiling of Compartmentalized Muscle and Brain Inflammation.
    Dobbertin T and Schirmer L. Eur J Immunol. 2025. 55(12):e70119.
    DOI: 10.1002/eji.70119.
12. Quantitative Sensory Testing in Endometriosis Patients With Cyclic vs. Non-Cyclic Pain-A Case-Control Study.
    Duckelmann AM et al. Eur J Pain. 2025. 29(10):e70163.
    DOI: 10.1002/ejp.70163.
13. Left atrial appendage occlusion in vulnerable oldest-old patients - Effectiveness and safety in a large single-center registry.
    Fastner C et al. J Neurol Sci. 2025. 473:123521.
    DOI: 10.1016/j.jns.2025.123521.
14. Microglia-neuron crosstalk via Hex-GM2-MGL2 maintains brain homeostasis.
    Frosch M et al. Nature. 2025.
    DOI: 10.1038/s41586-025-09477-y.
15. In vivo composition of the mitochondrial nucleoid in mice.
    Garcia-Villegas R et al. Biochim Biophys Acta Mol Cell Res. 2025. 1872(6):119955.
    DOI: 10.1016/j.bbamcr.2025.119955.
16. Increasing the smoking cessation success rate by enhancing improvement of self-control through sleep-amplified memory consolidation.
    Gerhardt S et al. BMC Psychol. 2025. 13(1):157.
    DOI: 10.1186/s40359-025-02482-w.
17. Abdominal pressure pain thresholds correlate with postoperative pain intensity.
    Ghanad E et al. Sci Prog. 2025.
    DOI: 10.1177/00368504251387759.
18. Somatosensory profiling to differentiate distinct painful diseases of the pancreas.
    Goltl P et al. Pain. 2025.
    DOI: 10.1097/j.pain.0000000000003601.
19. Identifying similar populations across independent single cell studies without data integration.
    Gonzalez-Velasco O et al. NAR Genom Bioinform. 2025.
    DOI: 10.1093/nargab/lqaf042.
20. Experimental investigation of self-inflicted versus other-inflicted injury behaviour in individuals with borderline personality disorder.
    Gortz A et al. Eur Arch Psychiatry Clin Neurosci. 2025.
    DOI: 10.1007/s00406-025-02059-z.
21. A sulfatide-centered ultra-high-resolution magnetic resonance MALDI imaging benchmark dataset.
    Gruber L et al. Gigascience. 2025.
    DOI: 10.1093/gigascience/giaf150.
22. Deep MALDI-MS spatial omics guided by quantum cascade laser mid-infrared imaging microscopy.
    Gruber L et al. Nat Commun. 2025.
    DOI: 10.1038/s41467-025-59839-3.
23. From Smoking to Vaping: The Motivation for E-cigarette Use at the Neurobiological Level.
    Grundinger N et al. Nicotine Tob Res. 2025.
    DOI: 10.1093/ntr/ntae273.
24. Metabolomic reprogramming of the tumor microenvironment by dual arginase inhibitor OATD-02 boosts anticancer immunity.
    Grzybowski MM et al. Sci Rep. 2025.
    DOI: 10.1038/s41598-025-03446-1.
25. Loss of global DNA hypermethylation is prognostic in IDH-mutant oligodendrogliomas.
    Hinz FE et al. Acta Neuropathol. 2025.
    DOI: 10.1007/s00401-025-02963-7.
26. Central projections of nociceptive input originating from the low back and limb muscle in rats.
    Hoheisel U et al. Sci Rep. 2025.
    DOI: 10.1038/s41598-025-86832-z.
27. The mGluR5 agonist CHPG enhances human oligodendrocyte differentiation.
    Huang Y et al. Acta Neuropathol Commun. 2025.
    DOI: 10.1186/s40478-025-02124-7.
28. Differentiating Glioma Recurrence and Pseudoprogression by APTw CEST MRI.
    Karimian-Jazi K et al. Invest Radiol. 2025.
    DOI: 10.1097/RLI.0000000000001145.
29. The role of the cingulum in deep brain stimulation of the limbic pain matrix.
    Kinfe T. Brain Commun. 2025.
    DOI: 10.1093/braincomms/fcaf225.
30. The Rise of Stereotactic Neurosurgery in Germany.
    Kinfe TM et al. J Neurol Surg. 2025.
    DOI: 10.1055/a-2558-3307.
31. Impact of respiration on abdominal pain thresholds in healthy subjects.
    Klick J et al. Scand J Pain. 2025.
    DOI: 10.1515/sjpain-2025-0001.
32. Multiple Sclerosis: Glial Cell Diversity in Time and Space.
    Kooistra SM et al. Glia. 2025.
    DOI: 10.1002/glia.24655.
33. Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma.
    Kourtesakis A et al. Oncoimmunology. 2025.
    DOI: 10.1080/2162402X.2025.2518631.
34. Intertwined destinies - Acute ischemic stroke and neurogenic stress cardiomyopathy.
    Kruska M et al. J Stroke Cerebrovasc Dis. 2025.
    DOI: 10.1016/j.jstrokecerebrovasdis.2024.108222.
35. Strength, extent and duration of secondary hyperalgesia induced by high-frequency electrical stimulation.
    Lebrun L et al. PLoS One. 2025.
    DOI: 10.1371/journal.pone.0318934.
36. Repeated exposure to cutaneous high-frequency electrical stimulation prolongs hyperalgesia.
    Lebrun L et al. J Neurophysiol. 2025.
    DOI: 10.1152/jn.00130.2025.
37. Myocardial injury in spontaneous intracerebral hemorrhage is not predicted by prior cardiac disease.
    Lesch H et al. Front Neurol. 2025.
    DOI: 10.3389/fneur.2025.1510361.
38. The phenomenon of dynamic change of cardiac troponin levels in intracerebral hemorrhage.
    Lesch H et al. J Neurol Sci. 2025.
    DOI: 10.1016/j.jns.2025.123633.
39. Management of persistent idiopathic facial pain (PIFP) - An international Delphi study.
    Lindfors E et al. Cephalalgia. 2025.
    DOI: 10.1177/03331024251399927.
40. ESPEC-SUIT: a versatile and robust platform to identify and track antigen-specific T cell receptors in patients with cancer.
    Lindner K et al. J Immunother Cancer. 2025.
    DOI: 10.1136/jitc-2025-012216.
41. Provision, cough efficacy and treatment satisfaction of mechanical insufflation-exsufflation in ALS.
    Maier A et al. Sci Rep. 2025.
    DOI: 10.1038/s41598-025-91692-8.
42. Local accumulation of very long-chain PUFA associates with retinal dysfunction.
    Merz J et al. Cell Mol Life Sci. 2025.
    DOI: 10.1007/s00018-025-05971-8.
43. SOD1 gene screening in ALS and transition to tofersen treatment.
    Meyer T et al. Amyotroph Lateral Scler Frontotemporal Degener. 2025.
    DOI: 10.1080/21678421.2024.2401131.
44. Shared prognostic information in amyotrophic lateral sclerosis.
    Mohwald LM et al. Neurol Res Pract. 2025.
    DOI: 10.1186/s42466-024-00363-y.
45. Association of the Cervical Canal Area With Disability in Multiple Sclerosis.
    Mongay-Ochoa N et al. Neurology. 2025.
    DOI: 10.1212/WNL.0000000000210136.
46. Exploring the Abeta Plaque Microenvironment in Alzheimer's Disease Model Mice.
    Muller E et al. Pharmaceuticals. 2025.
    DOI: 10.3390/ph18020252.
47. Computational identification of cross-reactive TCR epitopes with ARDitox.
    Murcia Pienkowski V et al. J Cancer Res Clin Oncol. 2025.
    DOI: 10.1007/s00432-025-06330-7.
48. The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability.
    Nochi Z et al. Anesthesiology. 2025.
    DOI: 10.1097/ALN.0000000000005694.
49. An inflammation-associated lncRNA induces neuronal damage via mitochondrial dysfunction.
    Olazagoitia-Garmendia A et al. Mol Ther Nucleic Acids. 2025.
    DOI: 10.1016/j.omtn.2025.102533.
50. Spatial lipidomics reveals demyelination and remyelination dynamics in the mouse brain.
    Opielka M et al. J Lipid Res. 2025.
    DOI: 10.1016/j.jlr.2025.100912.
51. Individualized patient tumor organoids preserve brain tumor ecosystems.
    Peng T et al. Cell Stem Cell. 2025.
    DOI: 10.1016/j.stem.2025.01.002.
52. Multimodal Quantitative MRI Atlas of the Human Brain in Healthy Young Adults.
    Pfirrmann J et al. J Neuroimaging. 2025.
    DOI: 10.1111/jon.70074.
53. Isocitrate dehydrogenase mutation and microenvironment in gliomas.
    Platten M. Curr Opin Neurol. 2025.
    DOI: 10.1097/WCO.0000000000001426.
54. Antiplatelet Use Prior to Anticoagulant Initiation in AF-related stroke.
    Polymeris AA et al. J Stroke. 2025.
    DOI: 10.5853/jos.2024.04322.
55. Neural, psychological, and daily life evidence for affective dysregulation.
    Renz MP et al. Pain. 2025.
    DOI: 10.1097/j.pain.0000000000003800.
56. Hippocampal contributions to semantic memory retrieval.
    Sandikci V et al. J Neuropsychol. 2025.
    DOI: 10.1111/jnp.12430.
57. Deep clinical, genetic, and serum biomarker profiling in brain calcification.
    Schwahn J et al. Brain Commun. 2025.
    DOI: 10.1093/braincomms/fcaf388.
58. Intravenous thrombolysis before PCI in stroke and ACS.
    Sedghi A et al. Open Heart. 2025.
    DOI: 10.1136/openhrt-2025-003567.
59. Nanodroplet Array Platform for MEK inhibitor discovery.
    Seifermann M et al. Angew Chem. 2025.
    DOI: 10.1002/anie.202507586.
60. Antigen-specific activation of gut immune cells drives autoimmune neuroinflammation.
    Siewert LK et al. Gut Microbes. 2026.
    DOI: 10.1080/19490976.2025.2601430.
61. Sex differences in phenotypic modulation of microglia.
    Singhal D et al. Pflugers Arch. 2025.
    DOI: 10.1007/s00424-025-03125-0.
62. Sex Differences in Early Life Stressors in low back pain.
    Singhal D et al. Eur J Pain. 2025.
    DOI: 10.1002/ejp.70114.
63. Tailoring anaesthetic strategies for diabetes research.
    Soares S et al. PLoS One. 2025.
    DOI: 10.1371/journal.pone.0316570.
64. Microvascular Perfusion MRI Improves Therapy Monitoring in Gliomas.
    Stadlbauer A et al. AJNR. 2025.
    DOI: 10.3174/ajnr.A8922.
65. Targeted Proteomics upon Treatment with Tofersen.
    Steffke C et al. Ann Neurol. 2025.
    DOI: 10.1002/ana.70025.
66. Self-assessment of ALS functional rating scale via smartphone.
    Steinfurth L et al. 2025.
    DOI: 10.1080/21678421.2025.2468404.
67. Treatment of glioblastoma patients with personalized vaccines outside trials.
    Tabatabai G et al. Neuro Oncol. 2025.
    DOI: 10.1093/neuonc/noae225.
68. Prediction of tumor-reactive T cell receptors from scRNA-seq.
    Tan CL et al. Nat Biotechnol. 2025.
    DOI: 10.1038/s41587-024-02161-y.
69. Disease-State Dependent Associations Between Brain Function and Symptoms in Crohn's Disease.
    Thomann AK et al.
    DOI: 10.1093/ibd/izae318.
70. Live imaging of excitable axonal microdomains in mice.
    Thome C et al. Elife. 2025.
    DOI: 10.7554/eLife.87078.
71. How to classify patients suffering from chronic pain associated with infectious diseases.
    Treede RD. Pain. 2025.
    DOI: 10.1097/j.pain.0000000000003644.
72. Slow depolarizing electrical stimuli reveal nociceptor recovery.
    Tumbala Gutti D et al. Eur J Pain. 2025.
    DOI: 10.1002/ejp.4726.
73. Systematic Review: Antidepressants and Insomnia in Children.
    Turkmen C et al.
    DOI: 10.1016/j.jaac.2025.01.006.
74. tDCS as add-on treatment for substance use disorder.
    Vollstadt-Klein S et al.
    DOI: 10.1186/s40359-025-03506-1.
75. Cognitive performance in stroke with myocardial injury.
    von Rennenberg R et al.
    DOI: 10.1186/s42466-025-00446-4.
76. Glioblastoma in adults: SNO/EANO consensus review.
    Wen PY et al.
    DOI: 10.1093/neuonc/noaf177.
77. Glucose intake reduces alcohol craving in AUD.
    Wetzel L et al.
    DOI: 10.1016/j.psyneuen.2025.107456.
78. Glucose Intake Reduces Craving Depending on Insulin Response.
    Wetzel L et al.
    DOI: 10.1159/000546648.
79. Molecularly matched targeted therapies plus radiotherapy in glioblastoma.
    Wick W et al.
    DOI: 10.1038/s41591-025-03928-9.
80. Emerging mechanisms and therapeutics in inflammatory muscle diseases.
    Wischnewski S et al.
    DOI: 10.1016/j.tips.2025.01.005.
81. Viral strategies to target norepinephrine neurons in locus coeruleus.
    Wissing C et al.
    DOI: 10.1371/journal.pbio.3003228.
82. Neoadjuvant immune checkpoint inhibition improves protection against melanoma metastasis.
    Wohlfeil SA et al.
    DOI: 10.1016/j.canlet.2025.217950.
83. ALS Mutations Shift the Isoelectric Point of the KIF5A C Terminal.
    Zanella P et al.
    DOI: 10.1523/JNEUROSCI.1658-24.2025.